As of Dec 14
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 29.00, with a high estimate of 32.00 and a low estimate of 25.00. The median estimate represents a +55.41% increase from the last price of 18.66.
The current consensus among 3 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.